Tashbib Khan
4PUBLICATIONS
38CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 27, 2025
Receptor CDCP1 Is a Potential Target for Personalized Imaging and Treatment of Poor Outcome HER2+, Triple-Negative, and Metastatic ER+/HER2- Breast Cancers.Madeline Gough, Kayden K X Kwah, Tashbib Khan
|Sep 28, 2021
Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer.Katherine B Sahin, Esha T Shah, Genevieve P Ferguson
|Apr 16, 2021
Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1.Thomas Kryza, Tashbib Khan, Scott Lovell
|Apr 09, 2020
Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma.Tashbib Khan, Yaowu He, Thomas Kryza
Pageof 1
Frequent Collaborators
4 joint publications
John D Hooper
3 joint publications
Yaowu He
2 joint publications
Thomas Kryza
1 joint publications
Jennifer H Gunter
1 joint publications
Andy C Wu
1 joint publications
Thomas McGann
1 joint publications
Josephine M Forbes
1 joint publications
Brittney S Harrington
1 joint publications
Julia Yin
1 joint publications
Hannu Koistinen
